News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProNAi Therapeutics, Inc. and Novosom Announce Collaboration to Enable Delivery of DNAi(R)-Based Cancer Therapeutics



3/6/2007 1:12:57 PM

KALAMAZOO, Mich. and HALLE, Germany--(BUSINESS WIRE)--ProNAi Therapeutics, Inc., a biopharmaceutical company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAiĀ®), today announced a collaboration with Novosom AG to enable successful delivery of DNAiĀ®-based cancer therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES